Intensive Care Treatment of Cardiogenic Shock and Post-cardiac Arrest Patients Registry

Recruiting

• Conditions: R57.0; I46; Cardiogenic shock; Cardiac arrest

• Registration Number: DRKS00015860
• Lead Sponsor: Klinikum der Universität München, Campus Großhadern

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2019-11-21
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

Patients with cardiogenic shock or after cardiopulmonary resuscitation of any cause with a minimum age of 18 years, who have been treated on the intensive care unit since the year 2012. Cardiogenic shock was defined by ESC guidelines, the IABP-SHOCK II trial and CULPRIT Shock trial as follows: hypotension despite adequate filling status (systolic blood pressure < 90 mmHg for 30 minutes or catecholamines to maintain systolic blood pressure > 90 mmHg) and signs of pulmonary congestion and at least one of the following clinical and laboratory signs of hypoperfusion: altered mental status, dizziness, cold, clammy skin and extremities, oliguria with urine output < 30ml/h, narrow pulse pressure, metabolic acidosis, elevated serum lactate > 2mmol/l, elevated creatinine, due to primary cardiac dysfunction.

Exclusion Criteria

Not provided

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
ong-term survival after 1, 5 and 10 years.